Asset Details
Do you wish to reserve the book?
Effect of weight reduction on the quality of life in obese patients with fibromyalgia syndrome: a randomized controlled trial
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Effect of weight reduction on the quality of life in obese patients with fibromyalgia syndrome: a randomized controlled trial
Do you wish to request the book?
Effect of weight reduction on the quality of life in obese patients with fibromyalgia syndrome: a randomized controlled trial
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Effect of weight reduction on the quality of life in obese patients with fibromyalgia syndrome: a randomized controlled trial
2012
Overview
The aim of the study was to examine whether weight reduction can result in improvement of fibromyalgia impact questionnaire (FIQ) in the patients with fibromyalgia syndrome (FMS). This study was a randomized controlled trial. Obese patients with fibromyalgia were randomly assigned to 6-month dietary weight loss (
n
= 41) and no weight loss (
n
= 42) groups. Patients were assessed at baseline and at 6 months. The primary outcome measure was FIQ. Secondary measures included the tender point (TP) examination, Beck Depression Inventory-II, and Pittsburg Sleep Quality Index. Compared to the control group, patients who underwent weight reduction obtained significantly better FIQ (
p
= 0.007), lower mean TP count (
p
= 0.015), and lower mean TP pain rating in the lower body (
p
< 0.001). Patients who lost weight had less depression and better sleep quality than the controls. Patients who lost weight had significantly lower interleukin 6 and C-reactive protein levels than those in the control group (
p
= 0.034 and
p
= 0.007, respectively). Weight loss in obese patients with FMS leads to significant improvement in the quality of life as shown by the decrease in the FIQ score. Depression, sleep quality, and tender point count are also significantly improved by weight loss in obese patients with fibromyalgia. Our results suggest that weight reduction should be a part of fibromyalgia treatment.
Publisher
Springer-Verlag,Springer Nature B.V
Subject
